Search concepts
|
Selected Filters
|
- 200 - 250 out of 1,415 results
Search results
-
Active
Understanding the mechanisms that regulate cytoplasmic capping and defining its contributions to post-transcriptional gene regulation (Same as parent grant)
6/1/22 → 6/30/25
Project: Federal Funding Agencies
-
-
Linked by Love: An African-American Family Story About Kidney Disease.
6/1/22 → 1/31/24
Project: Federal Funding Agencies
-
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
6/1/22 → 5/31/27
Project: Federal Funding Agencies
-
Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (?READISCA?)
6/1/22 → 12/31/23
Project: Federal Funding Agencies
-
VENOUS: A translational study of enterococcal bacteremia
6/1/22 → 5/31/25
Project: Federal Funding Agencies
-
Imaging for Precision Medicine in Alzheimer's Disease and Related Disorders
Masdeu, J. C., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O., Pascual, B. & Roman, G. C.
5/25/22 → …
Project: Clinical Trial
-
A Phase IIa randomized, double-blind, placebo-controlled study of the effects of L-serine on Mild Cognitive Impairment (MCI)
5/23/22 → 5/22/26
Project: Non Profit
-
CY 6022-Open-Label Study of CK-3773274 for Patients with oHCM Cytokinetics
Nagueh, S., Buergler, J., Kurrelmeyer, K. M. & Nabi, F.
5/19/22 → …
Project: Clinical Trial
-
A randomized, double-blind, placebo-controlled, multicenter, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2/fibrosis 3 stage of liver fibrosis
Victor, III, D. W. & Kodali, S.
5/16/22 → …
Project: Clinical Trial
-
A Multicenter, Prospective, Open-label, Randomized Controlled Clinical Trial to Compare the Safety and Effectiveness of the VitaSmartTM Liver Machine Perfusion System with Static Cold Storage for Organ Preservation Prior to Liver Transplantation
Saharia, A., Ghobrial, R. M., Hobeika, M. J. & Mobley, C. M.
5/16/22 → …
Project: Clinical Trial
-
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
5/15/22 → 4/30/27
Project: Federal Funding Agencies
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
Exploring the role of estrogen receptor beta in progression and metastasis of Inflammatory breast cancer
5/1/22 → 11/30/24
Project: Federal Funding Agencies
-
Exploring the role of ER Beta in disease penetrance in individuals with Li- Fraumeni syndrome
5/1/22 → 12/31/23
Project: Federal Funding Agencies
-
Early Detection of Hepatocellular Carcinoma - Renewal Submission
4/21/22 → 2/28/27
Project: Federal Funding Agencies
-
Defining cellular mechanisms of chronic graft failure in transplanted hearts with single cell multi-omics
4/20/22 → 3/31/24
Project: Federal Funding Agencies
-
Photoacoustic Imaging to Guide Catheter Ablation of Cardiac Arrhythmias
4/18/22 → 3/31/24
Project: Federal Funding Agencies
-
XBP1 Inhibition and STING activation for the treatment of cancer
4/8/22 → 3/31/27
Project: Federal Funding Agencies
-
CONNECT-AV Post-Market Surveillance of WavelinQ EndoAVF System BD Bard
4/4/22 → …
Project: Clinical Trial
-
-
Defining Evolutionary Trajectories: Molecular adaptation to antibiotic resistance
4/1/22 → 3/31/24
Project: Federal Funding Agencies
-
Contractor shall provide certain breast health screening and diagnostic services
4/1/22 → 4/1/24
Project: Non Profit
-
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
3/24/22 → 2/29/24
Project: Federal Funding Agencies
-
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
3/1/22 → 2/28/26
Project: Federal Funding Agencies
-
Role of B-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae
3/1/22 → 2/29/24
Project: Federal Funding Agencies
-
The Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)
Victor, III, D. W. & Kodali, S.
2/25/22 → …
Project: Clinical Trial
-
Human Astrocyte-Based Nanovesicles to Target Neuroinflammation in Alzheimer?s Disease
2/15/22 → 1/31/24
Project: Federal Funding Agencies
-
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
2/1/22 → 1/31/25
Project: Federal Funding Agencies
-
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
2/1/22 → 5/31/25
Project: Federal Funding Agencies
-
Bioenergetic potentiation in Alzheimer's Disease as a therapeutic strategy
2/1/22 → 1/31/25
Project: Non Profit
-
The LiaFSR system and antimicrobial peptide resistance in enterococci
2/1/22 → 6/30/24
Project: Federal Funding Agencies
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Butler, E. B., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
A structure-based machine learning framework to engineer antibody stability maturation and affinity
1/3/22 → 4/30/24
Project: Federal Funding Agencies
-
A Spectroscopic Approach to Overcome the Barriers of Early Familial Hypercholesterolemia Diagnosis
1/1/22 → 12/31/23
Project: Federal Funding Agencies
-
Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-Filled Breast Implants SmoothSilk in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery
Ellsworth, IV, W. A., Gratzon, A. C. & Spiegel, A.
12/29/21 → …
Project: Clinical Trial
-
-
-
Harnessing neuroplasticity of postural sensorimotor networks using non-invasive spinal neuromodulation to maximize functional recovery after spinal cord injury
Sayenko, D., Barber, S., Horner, P. J., Kaldis, T. & Vahidy, F. S.
12/1/21 → 8/31/27
Project: Federal Funding Agencies
-
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-